Doctor's Choice hands out honors

Share this article:
Merck's Fosamax three-page professional ads and Daiichi Sankyo's one-page Evoxac ad took top honors at the Doctors' Choice Awards.

The Fosamax ad, executed by FCB HealthCare, won the generalist physician category, while the Evoxac ad, by Torre Lazur McCann, won the physician specialty category.

In anti-infectives, an ad for Pfizer's Zyvox by Cline, Davis & Mann took top honors. In cardiovascular, an ad for Merck/Schering-Plough's Vytorin, by Surge Worldwide Healthcare, won first place. In psychiatrics, Forest and KPR won for Campral, and in oncologicals, Genentech and Harrison & Star won for an Avastin ad.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...